• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Albemarle Announces Enhanced Organizational Structure

    8/11/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email

    Aligns the company's functional model for greater agility and efficiency and is designed to accelerate market-led growth and operational excellence

    CHARLOTTE, N.C., Aug. 11, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced changes to its organizational structure to further align the company for agility and efficiency. These enhancements are designed to accelerate the company's market-led enterprise strategy and focus on operational excellence.

    Albemarle Corp. Logo. (PRNewsFoto/Albemarle Corporation)

    Effective as of today:

    • Mark Mummert will lead an integrated function of resources, manufacturing, capital and supply chain as chief operations officer continuing to report to Kent Masters, Albemarle's chairman and CEO. In this role, he will ensure optimization of Albemarle's world-class resources, including joint venture management, as well as global manufacturing. In addition, he will oversee capital projects and supply chain in a fully integrated operating model. With this change, Netha Johnson is leaving the company.
    • Autumn Gagarinas will become Albemarle's chief people and workplace transformation officer, also reporting to Masters, to focus on talent and culture, as well as business process and technology optimization. Autumn has been serving as Albemarle's vice president of human resources for over two years and has over two decades of human resources experience.
    • Melissa Anderson will continue to report to Masters and will lead Albemarle's enterprise strategy and growth, as well as research and technology as chief business transformation officer.

    "Our enhanced structure is intended to make us more agile and competitive as we navigate an increasingly dynamic market," Masters said. "With better functional alignment, we can maximize our world-class resources and manufacturing for operational excellence, focus our strategy on growth and customers, and combine people with technology to fully leverage our workforce's deep expertise."

    About Albemarle

    Albemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com, LinkedIn and on X (formerly known as Twitter) @AlbemarleCorp.

    Albemarle regularly posts information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.

    Forward-Looking Statements

    This press release contains statements concerning our expectations, anticipations, intentions, beliefs or strategies regarding the future, which constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions and events to differ materially from those anticipated, often contain words such as "anticipate," "believe," "could," "estimate," "expect," "focus," "intend," "may," "should," "would," "will" and variations of such words and similar expressions. Forward-looking statements may include, without limitation, statements regarding future or expected: operating structure, cost savings, long-term competitiveness, industry growth potential, market conditions, and all other information relating to matters that are not historical facts. Factors that could cause our actual results to differ materially from the outlook expressed or implied in any forward-looking statement include, without limitation: changes in economic and business conditions; adverse changes in liquidity or financial or operating performance; fluctuations in lithium market prices, and the other factors detailed from time to time in the reports we file with the U.S. Securities and Exchange Commission, including those described under "Risk Factors" in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. These forward-looking statements speak only as of the date of this press release. We assume no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

    Media Contact: Peter Smolowitz, +1 (980) 308-6310, [email protected]

    Investor Relations Contact: +1 (980) 299-5700, [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/albemarle-announces-enhanced-organizational-structure-302526757.html

    SOURCE Albemarle Corporation

    Get the next $ALB alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    7/30/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    7/29/2025$60.00Neutral → Underperform
    Robert W. Baird
    7/11/2025$57.00Neutral → Sell
    UBS
    2/5/2025Outperform → In-line
    Evercore ISI
    1/28/2025$96.00Hold
    Truist
    1/14/2025$112.00Buy
    Clarksons Platou
    8/5/2024$102.00 → $85.00Outperform → Neutral
    Robert W. Baird
    7/31/2024$160.00 → $83.00Buy → Hold
    Berenberg
    More analyst ratings

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Albemarle downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Albemarle from Overweight to Sector Weight

    7/30/25 7:24:56 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Albemarle from Neutral to Underperform and set a new price target of $60.00

    7/29/25 7:36:15 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle downgraded by UBS with a new price target

    UBS downgraded Albemarle from Neutral to Sell and set a new price target of $57.00

    7/11/25 8:09:46 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel & Sec Krupa Ander C. was granted 7,430 shares, increasing direct ownership by 171% to 11,771 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    8/8/25 4:16:45 PM ET
    $ALB
    Major Chemicals
    Industrials

    New insider Krupa Ander C. claimed ownership of 4,341 shares (SEC Form 3)

    3 - ALBEMARLE CORP (0000915913) (Issuer)

    8/8/25 4:16:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    Director Oconnell Diarmuid B. was granted 2,762 shares, increasing direct ownership by 50% to 8,233 units (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    7/3/25 3:35:31 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    SEC Filings

    View All

    Albemarle Corporation filed SEC Form 8-K: Leadership Update

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    8/12/25 4:32:46 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Albemarle Corporation

    SCHEDULE 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    8/5/25 11:11:06 AM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation filed SEC Form 8-K: Leadership Update

    8-K - ALBEMARLE CORP (0000915913) (Filer)

    8/4/25 4:25:49 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ketjen Introduces New Breakthrough Catalyst Technology that Effectively Mitigates the Effects of Iron Poisoning in FCC Units

    Commercial trial demonstrates SaFeGuard's™ effectiveness in processing opportunity crudes Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing has launched SaFeGuard™, a new catalyst technology designed to address iron (Fe) poisoning in FCC units. In a recent 30-day full commercial trial, SaFeGuard™ demonstrated a 77% improvement in accessibility with a 50% inventory replacement enabling an increase in unit activity, improved bottoms cracking, and ability to process heavy iron-rich feedstocks. Further testing and predictive modeling suggest that a full 100% inventory changeout could yield up to a 130% increase in accessibility delivering additional improvement in

    8/20/25 12:02:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces Enhanced Organizational Structure

    Aligns the company's functional model for greater agility and efficiency and is designed to accelerate market-led growth and operational excellence CHARLOTTE, N.C., Aug. 11, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced changes to its organizational structure to further align the company for agility and efficiency. These enhancements are designed to accelerate the company's market-led enterprise strategy and focus on operational excellence. Effective as of to

    8/11/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces New General Counsel, Corporate Secretary and Chief Compliance Officer

    CHARLOTTE, N.C., July 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that Ander Krupa has been promoted to executive vice president, general counsel, corporate secretary and chief compliance officer. "Ander's demonstrated leadership, broad legal expertise, and deep institutional knowledge positions him well to assume strategic oversight of Albemarle's legal, ethics, risk, and compliance functions," said Kent Masters, Albemarle's Chairman and CEO. "We are c

    7/30/25 4:30:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

    4 - ALBEMARLE CORP (0000915913) (Issuer)

    11/7/23 4:39:49 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    View All

    Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

    Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

    6/19/24 7:00:00 AM ET
    $ALB
    Major Chemicals
    Industrials

    International Paper Announces Changes to Its Board of Directors

     Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

    5/23/24 10:51:00 AM ET
    $ALB
    $AVNT
    $IP
    Major Chemicals
    Industrials
    Paper
    Basic Materials

    Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023

    CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i

    8/2/23 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    12/5/24 7:27:01 PM ET
    $ALB
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Albemarle Corporation

    SC 13G - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 12:52:42 PM ET
    $ALB
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

    SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

    11/13/24 10:27:59 AM ET
    $ALB
    Major Chemicals
    Industrials

    $ALB
    Financials

    Live finance-specific insights

    View All

    Albemarle Reports Second Quarter 2025 Results

    CHARLOTTE, N.C., July 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2025. Second-Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.3 billion, including volume growth in Energy Storage (+15%) and Specialties (+6%).Net income of $23 million, or ($0.16) per diluted share attributable to common shareholders; adjusted diluted

    7/30/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Announces Quarterly Common Stock Dividend

    CHARLOTTE, N.C., July 22, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable October 1, 2025, to shareholders of record at the close of business as of September 12, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect wit

    7/22/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials

    Albemarle Corporation to Release Second Quarter 2025 Earnings Results on Wednesday, July 30, 2025

    CHARLOTTE, North Carolina, June 18, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its second quarter 2025 earnings after the NYSE closes on Wednesday, July 30, 2025. The company will hold a conference call to discuss its second quarter 2025 results on Thursday, July 31, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.al

    6/18/25 4:15:00 PM ET
    $ALB
    Major Chemicals
    Industrials